Rabies virus kills roughly 59,000 people every year, almost all of them in parts of Asia and Africa where vaccines and post-bite treatment are hard to come by. What makes the virus so lethal is the way it moves: it slips into nerve endings at a bite wound, rides the body’s own transport machinery toward the brain, and hides from the immune system the entire way. By the time symptoms appear, the infection is nearly always fatal. Only about 34 well-documented survivors of clinical rabies have ever been recorded. Yet rabies is also one of the most preventable fatal infections on the planet, with post-exposure treatment that works almost without exception when administered promptly.
How the Virus Gets In
Rabies virus enters the body through a bite wound, usually from an infected animal’s saliva. What happens next is remarkably specific. Rather than infecting the first cells it touches, the virus homes in on the neuromuscular junction, the point where a motor nerve meets a muscle fiber. Early studies showed that virus particles concentrate at sites rich in nicotinic acetylcholine receptors, the same molecular machinery muscles use to receive signals from nerves. One monoclonal antibody directed at the acetylcholine receptor’s alpha subunit actually blocked rabies virus from attaching to cultured muscle cells, suggesting the virus exploits part of this receptor complex as a doorway into the nervous system.1Virus Research. Rabies virus binding at neuromuscular junctions
Later work in nerve-muscle cocultures confirmed this picture in finer detail. Fluorescent labels for the acetylcholine receptor lined up precisely with virus particles at the neuromuscular junction, and markers for synaptic vesicles confirmed the virus was sitting right inside nerve terminals. Once there, the virus was found inside early endosomes, some of which had already become acidified, and over time the virus and its endosomal compartments accumulated further up nerve fibers and in nerve cell bodies, consistent with retrograde transport away from the muscle and toward the spinal cord.2PubMed. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures
Hijacking the Nerve Highway
Once rabies virus is inside a motor neuron, it has to travel a long way. From a bite on the hand, for instance, the virus needs to reach the spinal cord and then the brain, a journey of more than a meter through narrow axons. The virus accomplishes this by hitching a ride on the cell’s own internal transport system, specifically the dynein motors that carry cargo from nerve terminals back toward the cell body.3PubMed Central. Anterograde glycoprotein-dependent transport of newly generated rabies virus in dorsal root ganglion neurons
The virus does not just passively ride along, though. Research has shown that rabies virus binds a receptor called p75NTR, a protein normally used for nerve growth factor signaling, and this interaction actually speeds things up. Virus particles traveling with p75NTR moved faster, paused fewer times, and had higher instantaneous velocities than particles traveling without it. The virus effectively accelerates the neuron’s own retrograde transport machinery for its benefit.4PLOS Pathogens. Rabies Virus Hijacks and Accelerates the p75NTR Retrograde Axonal Transport Machinery
This transit phase explains the famously variable incubation period of rabies. A bite on the face means a short distance to the brain and a faster onset, sometimes as little as a few weeks. A bite on the foot means a much longer journey, and symptoms can take months to appear. The incubation period has been reported to stretch past a year in rare cases.
Hiding From the Immune System
Most viruses that take weeks or months to cause disease eventually get caught by the immune system. Rabies manages to stay hidden for an unusually long time, and this immune evasion is central to why it is so dangerous. The virus causes a non-lytic infection of neurons, meaning it does not kill the cells it infects, which in turn limits the inflammatory alarm signals that would normally attract immune cells. Research suggests that rabies actually depends on keeping the neuronal network intact, keeping inflammation low, and destroying the T cells that try to infiltrate the central nervous system in response to infection.5PubMed. Apoptosis and rabies virus neuroinvasion
At the molecular level, the virus deploys its P protein to interfere with the signaling pathways that cells use to fight off infection. The P protein targets STAT1 and STAT2, key relay molecules in the interferon response that normally activates antiviral defenses. Research has also shown that the P protein interacts with activated STAT3 and inhibits signaling through the Gp130 receptor, broadening the range of immune pathways the virus can suppress.6PubMed Central. The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling
The result is a virus that slips past immune defenses for the entire duration of its journey to the brain. By the time the body mounts a detectable immune response, the virus is already established in the central nervous system, where immune cells have limited access and the virus has already done its damage.
What Happens When Symptoms Appear
Once rabies virus reaches the brain, the clinical picture unfolds rapidly and distinctly. The most recognizable symptom is hydrophobia, the dramatic, involuntary fear of water that is unique to human rabies. Hydrophobia involves paroxysmal contractions of the pharynx that produce violent spasms when a patient tries to swallow or even sees water.7PubMed Central. Hydrophobia of human rabies The “furious” form of rabies, which accounts for the majority of human cases, also features agitation, hallucinations, and episodes of aggression. A “paralytic” form, less commonly recognized, progresses more slowly and resembles ascending paralysis, sometimes leading to misdiagnosis.
Both forms are almost universally fatal once clinical signs begin. The virus does not destroy neurons outright, which is paradoxically part of the problem. Because the neurons remain structurally intact, there is less tissue damage for imaging to detect and less inflammation for the immune system to respond to, which is exactly how the virus wants it. But neuronal function is profoundly disrupted, and once the brainstem and critical regulatory centers are involved, the damage is irreversible.
Why Treatment After Symptoms Is So Elusive
In 2004, a teenage patient in Milwaukee survived clinical rabies after a treatment protocol involving induced coma, ketamine, and antiviral drugs. The approach, dubbed the “Milwaukee protocol,” was promoted heavily as a potential breakthrough. Over the subsequent two decades, however, no subsequent detailed reports documented evidence that the protocol itself was effective. At least 64 cases using the protocol resulted in failure, and the few additional survivors of clinical rabies had variable treatment and unclear attribution to any specific intervention.8PubMed Central. Demise of the Milwaukee Protocol for Rabies
A recent review concluded that aggressive critical care, which has been used in rabies management for over 50 years, is likely the more important component for any patient who does survive, and that the Milwaukee protocol should be abandoned in favor of new approaches grounded in better understanding of rabies pathogenesis.9PubMed Central. Demise of the Milwaukee Protocol for Rabies Among the roughly 34 well-documented survivors, many suffered serious neurological consequences. The honest reality is that once rabies becomes symptomatic, medicine has very little to offer.
Post-Exposure Prophylaxis Still Works Remarkably Well
The sharp contrast to the hopelessness of treating clinical rabies is the near-perfect effectiveness of post-exposure prophylaxis, the combination of wound care, vaccine doses, and rabies immunoglobulin given after a potential exposure but before symptoms develop. In one study of 95 subjects who received post-exposure prophylaxis with currently available rabies vaccines and immunoglobulin, all were healthy and alive after one year. All 27 subjects tested for rabies virus neutralizing antibodies on day 14 had adequate levels, with a geometric mean concentration well above the protective threshold.10Global Vaccines and Immunology. Safety, immunogenicity and clinical efficacy of post exposure prophylaxis in confirmed rabies exposures
A phase 2/3 trial comparing human rabies immune globulin co-administered with active vaccine found that about 98% of subjects had protective antibody levels by day 14.11PubMed Central. Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects The immunoglobulin floods the wound site with ready-made antibodies to neutralize the virus immediately, while the vaccine teaches the immune system to produce its own antibodies over the following days. Together, they cover the gap between exposure and immune response.
The problem is access. In many parts of the world where rabies kills the most people, human rabies immune globulin is expensive, scarce, and requires cold-chain storage. This is one reason monoclonal antibody cocktails are being developed as replacements. SYN023, a two-antibody cocktail, demonstrated neutralization equivalent or superior to human immune globulin against North American street rabies isolates in lab tests and protected hamsters against a highly virulent bat variant at a tiny fraction of the standard immunoglobulin dose.12PLOS Neglected Tropical Diseases. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies Another product, TwinRab, containing two monoclonal antibodies called docaravimab and miromavimab, was developed specifically for field adaptability, with stability features that could make it usable in high-burden regions with limited cold-chain infrastructure.13PubMed Central. In-Use Stability and Functional Efficacy of a Monoclonal Antibody Cocktail (TwinRabâ„¢) for Rabies Post-exposure Prophylaxis A phase 4 trial of another monoclonal antibody product used with purified rabies vaccine showed that no patients developed rabies during a one-year follow-up, with protective antibody levels maintained long-term.14PubMed. Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients
Who Is Most at Risk
The global burden of rabies falls overwhelmingly on low-income countries. An estimated 59,000 human deaths occur each year, with the vast majority concentrated in Asia and Africa where dog vaccination programs, timely diagnosis, and post-exposure treatment remain limited.15PubMed Central. Disparities in Global Rabies Burden from GBD 2021 Children are disproportionately affected. Analysis of global data from 1990 found that the highest incidence occurred among children aged 5 to 9, likely because children are more likely to interact with unfamiliar dogs and less likely to report a bite. The incidence drops through adolescence and early adulthood, though small upticks appear in older age groups. Among people 95 and older, incidence rates per 100,000 actually climbed to the highest of any age group, though absolute case numbers in the elderly remained very low.16PubMed Central. Disparities in Global Rabies Burden from GBD 2021
Dogs are the primary reservoir for rabies virus transmission to humans, responsible for the vast majority of human cases globally. But the virus circulates in a diverse range of wildlife. A modeling study using host traits predicted that dozens of carnivore and bat species could serve as rabies reservoirs: among 277 carnivore species evaluated, between 23 and 27 were confirmed reservoirs depending on how strictly the criteria were applied, and the model predicted an additional 38 to 44 carnivore species could potentially maintain the virus. Among 326 bat species, between 29 and 41 were confirmed reservoirs, with models predicting up to 34 additional bat species.17PLOS Neglected Tropical Diseases. Using host traits to predict reservoir host species of rabies virus
How Rabies Survives in Wildlife Populations
One of the puzzles of rabies ecology is how the virus persists in animal populations at all. It kills most of the hosts it infects, which should burn through susceptible animals quickly and cause the virus to disappear. In vampire bat colonies, researchers found that persistence cannot occur within a single colony acting in isolation. Instead, the virus needs bat dispersal between colonies, combined with a surprisingly high frequency of immunizing non-lethal infections, to maintain itself at levels consistent with what is actually observed in the field.18PubMed Central. Resolving the roles of immunity, pathogenesis, and immigration for rabies persistence in vampire bats
In temperate bat species that hibernate, a different mechanism comes into play. The metabolic slowdown of hibernation appears to also slow viral replication, extending the incubation period substantially. In silver-haired bats, rabies virus overwintered in hibernating animals, but the incubation period stretched an additional six weeks compared to bats kept at ambient temperatures. Counterintuitively, bats with longer incubation periods were more likely to have virus that had spread to their salivary glands, meaning hibernation actually increased the likelihood of eventual transmission.19PLOS ONE. Overwintering of Rabies Virus in Silver Haired Bats (Lasionycteris noctivagans) A broader model of bat rabies seasonality proposed that this pattern sustains the virus across years: infected bats enter hibernation, survive the winter with slowed viral progression, and then transmit the virus to the annual birth pulse of susceptible young bats the following spring.20PubMed Central. Host and viral ecology determine bat rabies seasonality and maintenance
Vaccinating Wildlife From the Air
In countries that have dramatically reduced or eliminated rabies, mass dog vaccination has been the foundation. Modeling suggests the threshold is not particularly high: estimates of the basic reproduction number for dog rabies fall between about 1.6 and 2.3, implying that vaccinating somewhere between 39% and 57% of the dog population should be enough to prevent outbreaks.21PubMed. Immunization coverage required to prevent outbreaks of dog rabies That is a relatively modest threshold compared to diseases with higher transmissibility.
For wildlife, the challenge is that you cannot line up foxes or raccoons for injections. Oral rabies vaccination programs solve this by distributing vaccine-laden baits across the landscape, often dropped from aircraft. RABORAL V-RG, a recombinant vaccine using a vaccinia virus vector to express the rabies glycoprotein, has been the workhorse of these campaigns. Since 1987, about 250 million doses have been distributed globally with no reported adverse reactions in wildlife or domestic animals. Safety has been evaluated in over 50 vertebrate species, and the vaccine has been shown to work in foxes, raccoons, coyotes, skunks, raccoon dogs, and jackals. Its deployment contributed to eliminating wildlife rabies from Belgium, France, and Luxembourg, and eliminated the dog/coyote rabies virus variant from the United States.22PubMed Central. Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review
In the United States, coordinated oral vaccination beginning in 1995 has targeted raccoon rabies spread in eastern states and specific rabies virus variants in gray foxes and coyotes in Texas.23PubMed. Status of oral rabies vaccination in wild carnivores in the United States Canada has pursued similar strategies, and economic analyses have consistently shown that these programs produce benefit-to-cost ratios above 1.0, meaning they save more money in prevented cases and reduced animal control costs than they cost to run.24PubMed Central. Tactics and economics of wildlife oral rabies vaccination, Canada and the United States
The Bat Lyssavirus Problem
Rabies virus is just one member of a larger family called the lyssaviruses, and several relatives circulate in bat populations across Europe, Africa, and Asia. Current rabies vaccines provide good cross-protection against lyssaviruses within phylogroup I, the group that includes classic rabies virus plus several bat lyssaviruses such as European bat lyssavirus 1, European bat lyssavirus 2, and Bokeloh bat lyssavirus. An inactivated veterinary rabies vaccine significantly cross-protected mice challenged with all three of these European bat lyssaviruses.25PubMed Central. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe
But phylogroup II lyssaviruses and other more divergent members of the family are a different story. Current rabies vaccines do not protect against them. Animals immunized with the standard vaccinia-rabies glycoprotein vaccine were not protected against challenge with Mokola virus or West Caucasian bat virus, two divergent lyssaviruses, and their sera showed no neutralization of those viruses.26PubMed Central. Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes This has raised questions about whether a pan-lyssavirus vaccine is needed, one that could cover the full spectrum of known lyssaviruses rather than just the phylogroup I cluster.27PubMed. Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? For now, the practical risk from divergent lyssaviruses to the general public is very low, since human exposure typically comes from bat handling. But for bat researchers and wildlife workers, the gap in vaccine coverage is a real occupational concern.
Two Evolutionary Lineages
Genomic analysis of hundreds of rabies virus sequences has revealed that the virus falls into two major phylogenetic groups with quite different evolutionary histories: bat-related rabies virus and dog-related rabies virus. These two lineages experience markedly different evolutionary dynamics, shaped by the different ecologies and behaviors of their hosts.28PLOS Pathogens. Large-Scale Phylogenomic Analysis Reveals the Complex Evolutionary History of Rabies Virus in Multiple Carnivore Hosts The bat lineage likely represents the older branch, and the virus has jumped between host species multiple times across continents. Each jump into a new host species appears to be a distinct evolutionary event, with the virus adapting to its new host over time. This history of repeated host shifts is part of what makes rabies virus so ecologically flexible and so difficult to fully eradicate worldwide.
Rabies Virus as a Neuroscience Tool
The same property that makes rabies virus so dangerous, its ability to travel along nerve fibers and jump across synaptic connections, has made it extraordinarily useful in neuroscience research. Modified versions of rabies virus that cannot replicate on their own are used to map neural circuits, revealing which neurons are connected to which. The basic approach works like this: a genetically modified rabies virus is introduced into a target cell type in the brain. The virus crosses one synapse and labels the neurons that directly connect to the target cell, but because it has been engineered to lack a key protein, it cannot spread any further. The result is a precise map of the monosynaptic inputs to a specific cell population.29PubMed Central. Monosynaptic circuit tracing in vivo through Cre-dependent targeting and complementation of modified rabies virus
This technique has become a standard method in systems neuroscience, and ongoing improvements have dramatically increased its power. An engineered version of the rabies glycoprotein called “oG” improved the efficiency of transsynaptic spread by more than an order of magnitude compared to the original version, meaning far more connected neurons get labeled per experiment.30Cell Reports. Improved Monosynaptic Neural Circuit Tracing Using Engineered Rabies Virus Glycoproteins More recently, a suite of 20 new recombinant rabies virus vectors has expanded the toolkit further, enabling applications from live calcium imaging of neuronal activity to detection of microstructural changes in neurons in mouse models of Alzheimer’s disease. Some versions encode reporters visible under electron microscopy, allowing circuit mapping across multiple imaging scales.31PubMed Central. New rabies viral resources for multi-scale neural circuit mapping
It is a strange twist that one of humanity’s oldest and most feared pathogens has become one of the most versatile instruments for understanding how the brain is wired. The virus’s evolutionary refinement of axonal transport and synaptic crossing, the same tricks it uses to reach the brain and cause fatal disease, turn out to be precisely the properties neuroscientists need to trace connections between brain cells with a precision no other tool can match.